# BeiGene

Type: Company (BGNE)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/beigene
Canonical HTML page: https://getbiobrief.com/entity/beigene

## Timeline

- **2030-12-31**: Healthy China 2030 Deadline — Target date for achieving major healthcare and biotech self-sufficiency milestones.
- **2026-03-19**: Official Launch — President Xi Jinping unveils the 15th FYP at the National People's Congress.
- **2026-03-07**: 15th FYP Announcement — China officially prioritizes tech self-reliance as the central pillar of the 2026-2030 plan.
- **2026**: Implementation Phase — Expected rollout of specific subsidies and domestic-first procurement policies.
- **2025-10-15**: 15th FYP Drafting — Central Committee reviews the initial draft of the 2026-2030 strategic plan.
- **2024**: Geopolitical Escalation — U.S. introduces Biosecure Act, targeting major Chinese biotech entities.
- **2021**: 14th Five-Year Plan — Initial focus on 'Dual Circulation' and building basic biotech infrastructure.
- **2021**: 14th FYP Implementation — Focus on 'Dual Circulation' and initial biotech innovation pivot.

## Recent coverage (2 stories)

### China's 15th Five-Year Plan: Xi's Vision for Biotech Sovereignty
2026-03-19 15:33:27 · Sentiment: Neutral · Impact: 8/10 · Sources: 2

President Xi Jinping’s 15th Five-Year Plan (2026-2030) positions biotechnology as a cornerstone of "New Quality Productive Forces," prioritizing domestic innovation and supply chain self-sufficiency. This strategic shift aims to decouple China’s life sciences sector from Western dependencies while accelerating the commercialization of cell and gene therapies.
Full story: https://getbiobrief.com/story/china-15th-five-year-plan-biotech-sovereignty

### China Targets Biotech Autonomy in Strategic 15th Five-Year Plan
2026-03-07 15:42:14 · Sentiment: Neutral · Impact: 8/10 · Sources: 2

China has officially signaled a shift toward total technological self-reliance in its 15th Five-Year Plan, prioritizing the domestic life sciences and pharmaceutical sectors. This strategic pivot aims to insulate China’s healthcare infrastructure from global supply chain volatility and geopolitical pressures while fostering a homegrown innovation ecosystem.
Full story: https://getbiobrief.com/story/china-biotech-self-reliance-15th-five-year-plan

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.